More on ACRV

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.1 Score)

Upcoming Events

- Earnings (11/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Acrivon Therapeutics (NQ:ACRV)
Delayed: 1.64 -0.12 (6.82%)
Prev. Close $1.76  
Open$1.75 
52 Wk High$ 
52 Wk Low$ 
Day High$1.77 
Day Low$1.63 
P/E N/A  
EPS$ 
Volume266,079 

Friends, Peers and Foes (?): ERAS, INCY, KPTI, ONCY, FHTX (more...)

Oct 7, 2026 05:02 PM Form 4 Acrivon Therapeutics, For: Oct 05 Filed by: Miller Mary
Sep 2, 2026 08:00 AM Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare Conference
Aug 31, 2026 08:32 AM Acrivon Therapeutics names Michaela Levin as chief business officer
Aug 31, 2026 08:30 AM Acrivon Therapeutics Appoints Michaela Levin, Ph.D., as Chief Business Officer
Aug 27, 2026 04:15 PM Form 4 Acrivon Therapeutics, For: Aug 25 Filed by: Blume-Jensen Peter
Aug 25, 2026 08:40 PM Form 144 Acrivon Therapeutics, Filed by: Blume-Jensen Peter
Aug 20, 2026 04:10 PM Form 4 Acrivon Therapeutics, For: Aug 18 Filed by: Peterson Katharine
Aug 20, 2026 04:09 PM Form 4 Acrivon Therapeutics, For: Aug 18 Filed by: Miller Mary
Aug 20, 2026 04:08 PM Form 4 Acrivon Therapeutics, For: Aug 18 Filed by: Gamelin Erick
Aug 20, 2026 04:08 PM Form 4 Acrivon Therapeutics, For: Aug 18 Filed by: Devroe Eric
View All Articles

Entities mentioned with ACRV

View All Entities